[Federal Register Volume 65, Number 163 (Tuesday, August 22, 2000)]
[Notices]
[Page 50995]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-21248]



[[Page 50995]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Joint Meeting of the Pediatric Subcommittee of the Anti-Infective 
Drugs Advisory Committee With the Pregnancy Labeling Subcommittee of 
the Advisory Committee for Reproductive Health Drugs; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Names of Committees: Joint meeting of the Pediatric Subcommittee of 
the Anti-Infective Drugs Advisory Committee with the Pregnancy Labeling 
Subcommittee of the Advisory Committee for Reproductive Health Drugs.
    General Function of the Committees: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on September 12, 2000, 1 
p.m. to 5:30 p.m.
    Location: Hyatt Regency, Baccarat/Haverford Rooms, One Bethesda 
Metro Center, Bethesda, MD.
    Contact Person: Jayne E. Peterson, Center for Drug Evaluation and 
Research (HFD-21), Food and Drug Administration, 5630 Fishers Lane, 
Rockville, MD 20857, 301-827-7001, e-mail: [email protected], or 
FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 
in the Washington, DC area), code 12530. Please call the Information 
Line for up-to-date information on this meeting.
    Agenda: The subcommittees will meet jointly to discuss existing 
information and needs with respect to prescription drug therapy in 
nursing mothers.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing on issues pending before the subcommittees. 
Written submissions may be made to the contact person by September 6, 
2000. Oral presentations from the public will be scheduled between 
approximately 3:15 p.m. and 4:15 p.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before September 6, 
2000, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses of 
proposed participants, and an indication of the approximate time 
requested to make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: August 10, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-21248 Filed 8-21-00; 8:45 am]
BILLING CODE 4160-01-F